European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer.

Dirk De Ruysscher, Corinne Faivre-Finn, Ditte Moeller, Ursula Nestle, Coen W. Hurkmans, Cecile Le Pechoux, José Belderbos, Matthias Guckenberger, Suresh Senan

Research output: Contribution to journalArticlepeer-review

586 Downloads (Pure)

Abstract

Purpose:
To update literature-based recommendations for techniques used in high-precision thoracic radiotherapy for lung cancer, in both routine practice and clinical trials.
Methods:
A literature search was performed to identify published articles that were considered clinically relevant and practical to use. Recommendations were categorised under the following headings: patient positioning and immobilisation, Tumour and nodal changes, CT and FDG-PET imaging, target volumes definition, radiotherapy treatment planning and treatment delivery. An adapted grading of evidence from the Infectious Disease Society of America, and for models the TRIPOD criteria, were used.
Results:
Recommendations were identified for each of the above categories.
Conclusion:
Recommendations for the clinical implementation of high-precision conformal radiotherapy and stereotactic body radiotherapy for lung tumours were identified from the literature. Techniques that were considered investigational at present are highlighted.
Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalRadiotherapy and Oncology
Volume124
Issue number1
Early online date27 Jun 2017
DOIs
Publication statusPublished - Jul 2017

Keywords

  • Radiotherapy
  • Lung cancer
  • recommendations
  • Guidelines
  • EORTC
  • stereotactic body radiotherapy (SBRT)
  • organs at risk
  • Toxicity

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer.'. Together they form a unique fingerprint.

Cite this